Spinnaker Investment Group’s Bristol-Myers Squibb BMY Stock Holding History

Spinnaker Investment Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,966	Closed	-$288K	–	85
2023 Q3	$288K	Buy	4,966 +211	+4%	+$12.9K	0.1%	71
2023 Q2	$304K	Buy	4,755 +45	+1%	+$3.02K	0.1%	68
2023 Q1	$326K	Buy	4,710 +183	+4%	+$12.9K	0.11%	66
2022 Q4	$326K	Buy	4,527 +150	+3%	+$11.3K	0.12%	66
2022 Q3	$311K	Buy	4,377 +450	+11%	+$32.6K	0.12%	63
2022 Q2	$302K	Sell	3,927 -604	-13%	-$46K	0.12%	60
2022 Q1	$332K	Buy	4,531 +555	+14%	+$37.3K	0.11%	64
2021 Q4	$258K	Buy	+3,976	New	+$233K	0.09%	78

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Spinnaker Investment Group's BMY Position: Q4 2023 in Review

Spinnaker Investment Group sold out of Bristol-Myers Squibb (BMY) in Q4 2023, closing a stake of 4,966 shares — an estimated $288K sold.

Spinnaker Investment Group first reported a position in BMY in Q4 2021 and held it in 8 quarters. The position peaked at $332K in Q1 2022. 2,363 funds tracked by Wall St. Rank hold BMY as of Q4 2023.

Spinnaker Investment Group reported no remaining Bristol-Myers Squibb position as of Q4 2023 after selling out during the quarter.
Spinnaker Investment Group sold 4,966 Bristol-Myers Squibb shares in Q4 2023, an estimated $288K.
Spinnaker Investment Group first reported a position in Bristol-Myers Squibb in Q4 2021 and held it in 8 quarters.
Spinnaker Investment Group's Bristol-Myers Squibb position peaked at $332K in Q1 2022.
2,363 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2023.

Based on Spinnaker Investment Group's 13F filing for Q4 2023, filed 22 Jan 2024.